Pharma Intelligence is part of the Business Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Get coverage of the latest pharmaceutical business developments, and historical metrics on financing, licensing, partnership, and acquisition.
Our trusted Pharma Intelligence brands
Datamonitor Healthcare
By Andrew Benson 23 Jul 2018
NSCLC is one of the hottest areas in Oncology today. Watch now "The Latest in Immuno-Oncology: A Deep Dive into Non-Small Cell Lung Cancer (NSCLC)", a webinar from Informa Pharma Intelligence. Our panel of experts provided their insights into the clinical landscape and commercial implications of NSCLC.
Pink Sheet
By Francesca Bruce 23 Jul 2018
Biogen, the first company to win a positive reimbursement decision from the BeNeLuxA groups, says the process was “constructive and collaborative.” However, differences in local laws mean there will initially be some differences in coverage.
Topic Business strategies
Pink Sheet
By Mandy Jackson 23 Jul 2018
Have pharma companies responded sufficiently to President Trump's call for “massive” price reductions?
Topic Strategy
Scrip
By Viren Mehta 20 Jul 2018
With money pouring into biopharma in China, and regulatory reforms favoring market growth and R&D speed, western firms should watch their backs, warns Viren Mehta, founding partner of Mehta Partners LLC.
Topic Policy and regulation
Scrip
By Jo Shorthouse 20 Jul 2018
Pharma has been busy making deals this year, while the political winds of change swirl overhead, as our infographic shows. Companies both big and small have been merging to carve out therapeutic niches, return value to shareholders, and position themselves for the next wave of innovation and change.
Topic Business strategies
Scrip
By Emily Hayes 18 Jul 2018
The Japanese pharma says it will discuss the data with US FDA, with hopes of potential to incorporate secondary endpoint data in labeling.
Topic Obesity Clinical trials
Scrip
By Jessica Merrill 18 Jul 2018
J&J told investors to anticipate negative net drug pricing of 4%-6% across its portfolio in 2018, following a 4.6% negative impact in 2017. CEO Alex Gorsky also cautioned against changing drug pricing policy too quickly.
Topic Policy and regulation
Medtech Insight
By Elizabeth Orr 17 Jul 2018
Major medical device companies paid almost $1bn in consulting fees, royalties, research costs and other expenses to physicians in 2017, the most recent data release from the US Open Payments database shows. Zimmer Biomet reported the highest spending on general physician payments, while Roche and Medtronic topped the list of research spending.
Topic Clinical trials
Medtech Insight
By Shawn M. Schmitt 17 Jul 2018
Bill Maisel – the director of the Office of Device Evaluation within US FDA's Center for Devices and Radiological Health (among other titles) – says there are four things device-makers should do to make sure they succeed during the product-review process.
Topic Business strategies
Pink Sheet
By Cathy Kelly 16 Jul 2018
Companies should introduce same drug under new NDC at lower list price to overcome difficulties of reducing list prices on existing brands, PBM says.
Topic Policy and regulation
Pink Sheet
By Francesca Bruce 16 Jul 2018
The UK government has finally published its white paper on the UK’s future relationship with the EU following Brexit, to the relief of the pharmaceutical industry.
Topic Brexit
Pharmaprojects
13 Jul 2018
The discovery and deep investigation of the microbiome has been one of the most significant recent biomedical advances. Extensive research suggests that dysbiosis of the gut microbiome plays a significant role in multiple gastrointestinal (GI) disorders such as; Crohn’s disease, ulcerative colitis, and irritable bowel syndrome (IBS).
Pharmaprojects
13 Jul 2018
Welcome to Pharmaprojects’ roundup of key trends in pharmaceutical R&D in 2018, focusing on five key takeaways from our full annual report
Scrip
By Jung Won Shin 13 Jul 2018
South Korean financial authorities conclude Samsung BioLogics violated accounting standards by omitting certain information on its joint venture agreement with Biogen from public disclosures, and have ordered further investigation of a corporate governance decision on the handling in accounts of the JV, Samsung Bioepis. The latest ruling in the prolonged affair could hurt the credibility and business of Samsung BioLogics going forward, although the firm maintains it has done nothing improper.
Topic Policy and regulation
Scrip
By Jessica Merrill 13 Jul 2018
Mylan has priced its biosimilar version of pegfilgrastim at a 33% discount to Amgen's WAC for Neulasta, steeper than the 15% discount Pfizer initially offered for Inflectra. The commercial outcome for Fulphila could set the tone for future US biosimilars, which have yet to take off.
In Vivo
23 Jul 2018
In Vivo
23 Jul 2018
Pink Sheet
20 Jul 2018
Medtech Insight
20 Jul 2018
Pink Sheet
20 Jul 2018
Scrip
20 Jul 2018
Scrip
20 Jul 2018
Scrip
20 Jul 2018
Scrip
20 Jul 2018
Medtech Insight
20 Jul 2018
Medtech Insight
20 Jul 2018
Scrip
20 Jul 2018
Scrip
20 Jul 2018
Medtech Insight
20 Jul 2018
Medtech Insight
20 Jul 2018
Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.
Key benefits:
Datamonitor Healthcare's expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions.
Key benefits:
Key benefits:
23 Sep 2018
USA
Awards
09 Oct 2018
Spain
Awards
28 Nov 2018
Awards
Request a live demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
How can we help you?
Our team is always happy to hear from you. Please call us at:
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
Keep up to date